The Medicines Evaluation Board (MEB) assesses and monitors the efficacy, risks and quality of human and veterinary medicines, and the safety of novel foods for human consumption.
The MEB is an independent administrative body residing under the Government of the Netherlands. The MEB independently decides about the authorisation and monitoring of human medicinal products.
Guidance on the Substantiation of Claims made on Animal Nutrition updated
The Guidance on the Substantiation of Claims made on Animal Nutrition has been updated as of 18 August 2016.
Start of European registration of PSURs
All PSURS for centrally and nationally authorised medicinal products in Europe must be submitted via the PSUR Repository as of...
Decision on objection buprenorphine Sandoz
During the meeting on 2 June 2016, the Medicines Evaluation Board (MEB) reached a decision regarding an objection submitted by...
MEB Day 2016: “Science and Europe”
“The Netherlands plays a key role in Europe with regard to medicines and the assessment of medicines,” explained MEB Chairman...